SCHEMBL3707902

SCHEMBL3707902

COCc1cc(C(F)(C(F)(F)F)C(F)(F)C(F)(F)F)cc(C)c1NC(=O)c1ccc(C#N)c(NC(=O)c2ccc(C#N)cc2C)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 4/20 0.36
BRAF P15056 1/20 0.35
NR1H4 Q96RI1 1/20 0.35
LRRK2 Q5S007 1/20 0.33
POLB P06746 1/20 0.33
PTGES O14684 1/20 0.33
ALB P02768 1/20 0.33
KMT2A Q03164 3/20 0.33
MEN1 O00255 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
PDE5A O76074 1/20 0.32
PDE1A P54750 1/20 0.32
PDE1B Q01064 1/20 0.32
PDE1C Q14123 1/20 0.32
MAPT P10636 1/20 0.32
KDM4E B2RXH2 1/20 0.31
HSD17B10 Q99714 1/20 0.31
S1PR3 Q99500 1/20 0.31
GPR6 P46095 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL290192 0.92 RXFP1 (0.36) RXFP1BRAFNR1H4LRRK2KMT2A
SCHEMBL289051 0.90 RXFP1 (0.39) RXFP1BRAFNR1H4LRRK2KMT2A
SCHEMBL3704888 0.88 PDE5A (0.38) RXFP1NR1H4LRRK2KMT2AMEN1
SCHEMBL31560030 0.88 RXFP1 (0.38) RXFP1BRAFNR1H4LRRK2KMT2A
SCHEMBL3708470 0.86 RXFP1 (0.34) RXFP1BRAFNR1H4LRRK2KMT2A
SCHEMBL3703139 0.85 KMT2A (0.39) RXFP1NR1H4LRRK2KMT2AMEN1
SCHEMBL3766659 0.85 RXFP1 (0.37) RXFP1BRAFNR1H4LRRK2KMT2A
SCHEMBL29362690 0.85 RXFP1 (0.37) RXFP1BRAFNR1H4LRRK2KMT2A
SCHEMBL29360734 0.85 KMT2A (0.39) RXFP1NR1H4LRRK2KMT2AMEN1
SCHEMBL3224628 0.84 S1PR3 (0.40) POLBKDM4ES1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106242998-B Use of 4-cyano-3-benzoylamino-N-phenyl-benzamides in pesticides 先正达参股股份有限公司 2021-11-05 CN disclosed
EP-2427427-B1 4-CYANO-3-BENZOYLAMINO-N-PHENYL-BENZAMIDES FOR USE IN PEST CONTROL SYNGENTA PARTICIPATIONS AG (CH) 2013-12-25 EP disclosed
US-8431514-B2 4-cyano-3-benzoylamino-N-phenyl-benzamides for use in pest control SYNGENTA CROP PROTECTION LLC (US) 2013-04-30 US disclosed
US-20120122975-A1 4-CYANO-3-BENZOYLAMINO-N-PHENYL-BENZAMIDES FOR USE IN PEST CONTROL SYNGENTA CROP PROTECTION LLC (US) 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122975-A1 4-CYANO-3-BENZOYLAMINO-N-PHENYL-BENZAMIDES FOR USE IN PEST CONTROL NISCH, AADAC, ACHE RXFP1 4237/4885BRAF 2923/4885NR1H4 2851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.